David Labuskes will retire from his current role at the end of 2026, after leading a transformative era for AVIXA and its ...
Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback